Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 12.61B | 11.42B | 16.25B | 18.71B | 16.62B |
Gross Profit | 1.63B | 1.37B | 1.58B | 2.19B | 1.96B |
EBITDA | 2.26B | 402.00M | 651.98M | 1.32B | 1.06B |
Net Income | 1.58B | 548.26M | 569.98M | 974.20M | 790.52M |
Balance Sheet | |||||
Total Assets | 15.86B | 17.14B | 15.61B | 16.87B | 16.15B |
Cash, Cash Equivalents and Short-Term Investments | 7.59B | 6.16B | 5.77B | 4.03B | 4.37B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 2.26B | 2.60B | 2.11B | 2.62B | 2.90B |
Stockholders Equity | 13.59B | 14.54B | 13.51B | 14.24B | 13.25B |
Cash Flow | |||||
Free Cash Flow | 500.71M | 551.90M | 2.52B | 94.59M | 332.71M |
Operating Cash Flow | 540.82M | 684.68M | 2.54B | 180.01M | 363.91M |
Investing Cash Flow | 1.56B | 166.77M | 19.76M | -93.61M | -40.68M |
Financing Cash Flow | -676.56M | -457.99M | -824.05M | -425.58M | -447.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | €670.73B | 15.72 | 18.55% | 3.53% | 10.88% | 14.80% | |
78 Outperform | $1.10T | 13.53 | 10.10% | 2.98% | 3.28% | 6.55% | |
77 Outperform | $238.16B | 10.18 | 9.01% | 3.02% | 0.32% | 31.76% | |
72 Outperform | ¥17.77B | 12.68 | 3.97% | 10.43% | 187.34% | ||
71 Outperform | $656.15B | 20.23 | 3.69% | 4.35% | 3.40% | -35.47% | |
70 Outperform | $1.15T | 25.68 | 2.49% | 3.94% | 0.46% | -62.37% | |
63 Neutral | $10.55B | 10.83 | 1.51% | 2.68% | 2.24% | -33.79% |
Japan Pure Chemical Co., Ltd. announced corrections to its non-consolidated financial results for the year ended March 31, 2025. The corrections involve adjustments in cash flow figures, specifically in operating and investing activities, which reflect minor changes in financial performance. These adjustments may impact stakeholders’ understanding of the company’s financial health and operational efficiency.
Japan Pure Chemical Co., Ltd. has announced its medium-term management plan for FY2025-2027, building on its RDD2030 vision. Despite a slower market recovery than expected, the company is focusing on strategic investments and strengthening its management infrastructure to enhance corporate and customer value, aiming to meet market and stakeholder expectations.
Japan Pure Chemical Co., Ltd. announced a revision to its executive remuneration system aimed at boosting motivation for sustainable growth and aligning with shareholder interests. The new system emphasizes performance-linked remuneration, introduces non-financial performance metrics, and includes non-performance-based stock remuneration for non-executive directors, reflecting a strategic shift to enhance corporate governance and long-term value creation.
Japan Pure Chemical Co., Ltd. announced proposed amendments to its Articles of Incorporation and changes in its board of directors, aiming to transition to a company with an audit and supervisory committee. This move is expected to enhance decision-making efficiency and strengthen the board’s supervisory function, potentially impacting the company’s governance and shareholder relations.
Japan Pure Chemical Co., Ltd. reported a significant increase in its financial performance for the fiscal year ended March 31, 2025, with net sales rising by 10.4% and net profit surging by 188.1% compared to the previous year. The company also announced an increase in annual dividends, reflecting its improved profitability and strong financial position, which could positively impact shareholders and enhance its market standing.